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INTRODUCTION
Nonvolatile metabolic waste products and toxins are eliminated from the body predominantly by the kidney and liver. In general, low molecular weight water-soluble substances with little or no protein binding are filtered by the glomerulus, a process for which dialysis can provide an effective substitute when renal function is inadequate. In contrast, substances which are relatively insoluble in aqueous solution and/or which are transported in plasma tightly bound to plasma proteins are excreted predominantly by the liver. Such substances are not effectively dialyzable, even when the binding protein is in the dialysate (1) . Although there are methods which may help the body to eliminate particular protein-bound substances such as bilirubin (2) (3) (4) (5) (6) (7) (8) , no general method like dialysis exists.
Stimulated by the need to remove bilirubin (BR)' from a patient with the Crigler-Najjar syndrome (congenital absence of glucuronyl transferase in the liver) whose clinical condition was deteriorating, we have applied the principle of affinity chromatography (9) to the removal of BR and other albumin-bound substances from plasma and whole blood. We have coupled albumin to various polymer beads and passed plasma and whole blood over the beads in chromatographic columns. Albumin-conjugated agarose beads will remove albumin-'Abbrevations used in this paper: BR, bilirubin; HSA, liuman serum albumin; PBS, 0.14 M sodium chlloride-0.01 bound substances from plasma and blood, and they appear compatible with whole blood. They have been used subsequently in an extracorporeal hemoperfusion system in rats, as reported in the accompanying paper (10) .
MATERIALS AND METHODS
Albumin. 25% human serum albumin (HSA) for injection from various manufacturers was supplied by the Bureau of Biologics of the Food and Drug Administration or was purchased from commercial sources. It was dialyzed in the cold for at least 18 h against 20 vol of the conjugation buffer, usually 0.1 M sodium bicarbonate, to remove sodium tryptophanate. The dialyzed albumin contained no detectable contaminating proteins when tested by immunoelectrophoresis with rabbit anti-whole human serum. Antibody raised in rabbits against one lot of the HSA reacted only with albumin in immunoelectrophoresis of whole human serum.
Agarose. Several kinds of agarose beads have been used, but in all the experiments reported here, Sepharose 6B 65-325 mesh (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) and Bio-Gel A5m 100-200 mesh (Bio-Rad Laboratories, Richmond, Calif.) were used. In preliminary experiments, the albumin-binding capacities of Sepharose 2B, Sepharose 4B, Bio-Gel A1.5m, and A50m were found to be less than 6B and A5m. In recent experiments we have used Bio-Gel A5m because its larger bead size allows better flow of whole blood. In addition, there is more binding of bilirubin.
Buffers. Phosphate-buffered saline (PBS) (0.14 M sodium chloride-0.01 M sodium phosphate, pH 7.2) was supplied by the Media Unit of the National Institutes of Health. All other solutions were made from reagent grade chemicals and triple-distilled water. Ethanol solutions were made just before use by mixing absolute ethanol or 95% ethanol and triple-distilled water.
Radioactive materials. ["C] BR was prepared as described earlier (11) . For In all experiments performed with these compounds, the compound was added to serum and the mixture was incubated at 37°C for 15-30 min to allow equilibration before addition to the gel. Thyroxine, cortisol, and the bile salts were added in trace amounts. Salicylate was added in a therapeutic concentration, and the digitalis preparations were added in concentrations found in clinical digitalis toxicity (Table III) . Indocyanine green (Hynson, Westcott, and Dunning, Inc., Baltimore, Md.) was added in a concentration of 12.5 mg/100 ml.
Preparation of agarose-albumin. After a series of experiments with various coupling methods and gels, we settled on a modification of the cyanogen bromide method of Axen, Porath, and Ernback to prepare agarose-albumin conjugates (12) . 40 g of agarose was weighed while wet, then washed on a scintered glass funnel with distilled water. The gel was added with an equal weight of water to a TPX beaker (Nalge Co., Nalgene Labware Div., Rochester, N. Y.). A stirring bar, a thermometer, and a pH electrode were added and the beaker was placed in a hood on a magnetic stirring table. Cyanogen bromide (Eastman, Rochester, N. Y.), 10 g, was added and the pH brought to about 10.5 with 2.5 N sodium hydroxide. For the next 10 min, 2.5 N NaOH and small amounts of ice were added to the reaction mixture to keep the pH at 10-11.5 and the temperature at 18-220C. Then a large quantity of ice was added, the activated gel was rapidly filtered and washed with at least 25 vol of ice cold 0.1 M sodium bicarbonate, and then added to a beaker containing HSA at 50-100 mg/ml in 0.1 M sodium bicarbonate. The beaker was rotated gently at 4°C overnight, and on the following day the gel was washed with PBS; 1.0 M NaCl4.1 M sodium acetate, pH 5.0; 0.2 M borate saline, pH 8.4; PBS; and in recent preparations, 50% ethanol in water (vol/vol) followed by PBS. The washed gel was then filtered through a coarse nylon mesh tea strainer and defined by repeated suspension in PBS in a TPX cylinder and stored in a TPX container in the ice box. The amount of albumin bound was determined by measuring the absorbance at 280 nm of the first wash. No substantial amount of protein was removed by subsequent washes. The results obtained by using absorbance were in close agreement with those obtained using ['2II]HSA. Because a small amount of radioactivity leaching from the gels would have complicated the measurement of radioactive compounds, ['1'I]HSA was not routinely used.
Usually, the agarose bound between 30 and 50 mg of HSA/g wet wt. This is equivalent to 30 to 50 mg HSA/ml (since the density of the wet gel is about equal to water), which is the same as the concentration of HSA in normal plasma.
Coupling at other pH's from 4 to 11 did not improve the albumin binding to agarose over that obtained in 0.1 M sodium bicarbonate. The prior conjugation of phlorglucinol to the beads with epichlorhydrin did not increase the amount of albumin bound (13) . Acrylamide beads conjugated with hydrazine hydrate and coupled to albumin via the acyl azide (14) bound less albumin than cyanogen bromide-activated agarose.
Columns. Agarose beads were allowed to settle by gravity into disposable polypropylene columns with 8-mm internal diameter (Chromaflex, Kontes Glass Co., Vineland, N. ). In experiments with serum or plasma, glass wool was used to retain the beads in the columns; in experiments with whole blood, nylon cloth (400 mesh) or stainless steel cloth (200 mesh) were fitted in the ends of the plastic columns between short lengths of Tygon tubing (Arthur H. Thomas Co., Philadelphia, Pa.).
Experimental design. Plasma containing the substance being tested was applied to an agarose-HSA column and the material that did not bind was collected along with PBS washes. We calculated the amount of substance bound as the difference between the amount added and the amount recovered with PBS washing. In most experiments, 1-5 ml plasma (or serum) equilibrated with radioactive compound was added to 3-10 g gel in a column and washed through with PBS. The flow was controlled with an LKB series 12000 pump (LKB Produkter, Bromma, Sweden) or by a needle on the column outflow and ranged from 0.3 to 3.0 ml/min. The unbound substances and the first wash with PBS were collected in 15-ml or 20-ml. Flution was then carried out with other salt solutions or ethanol in water and similar volumes were collected and aliquots taken for counting. Usually, two 15-ml fractions of PBS wash were collected and one 15-ml fraction of each eluate. Except as noted, there was rarely as much as 1 or 2%o of the total unbound material in the second PBS fraction, and it was occasionally omitted for convenience. All experiments were performed at room temperature. Experiments with BR were carried out in a darkened room, and the columns and collecting vessels were jacketed in aluminum foil.
Determination of protein. Albumin concentrations were determined by measuring the absorbance at 280 nm in a Zeiss spectrophotometer PMII using an extinction coefficient of El%280 = 5.3 (15 6 g/100 ml, and 1 part of 0.1 N hydrochloric acid. Thus the final solution contained 2 g HSA/100 ml '4 ml of an appropriate dilution of plasma in saline was divided into two 2.0-ml portions. To one was added 1.0 ml of sulfanilic acid reagent (4 g of sulfanilic acid and 60 ml of concentrated hydrochloric acid made to 1,000 ml with water) and 1.5 ml methanol. To the other was added 1.0 ml of diazo reagent (0.3 ml of a 2%o aqueous solution of sodium nitrite plus 10 ml of sulfanilic acid reagent) and 1.5 ml methanol. After 30 min, the optical density at 540 nm was determined. (Fig. 1) . In 55 experiments in which the amount bound (amount added minus amount in the PBS washes) and the amount eluted by 50% ethanol could be compared, the ratio of eluted/ bound was 0.99+.093 (SD).
After 50% ethanol elution, the beads were washed with PBS and stored in the ice box. Such used beads retained fully their capacity to bind bilirubin. In Table   II are shown the results of the repeated reuse over a 6-mo period of a single 10-g column to bind bilirubin from 1 ml of jaundiced plasma. This column was tested at well below its capacity in these experiments, but was shown to bind 40 'g/g of gel when a sample was exposed to an excess of BR at day 192.
We performed a series of experiments with a single batch of agarose-HSA in which a large amount of bilirubin and varying flow rates (0.5-2.5 ml per min) were used in order to stress the gels to near capacity. Part of the gel was stored unused for 3 wk, part was used and eluted only on the day after it was made, and part on the day it was made and then again on days 7 and 14. All portions of the gel were compared on day 20. The binding capacity was only slightly dependent on flow rate over the five-fold range tested. Furthermore, the binding capacity at various flow rates was negligiblychanged by either reuse or storage in the ice box. The amount bound represents the difference between the added BR and the amount recovered with PBS washes. ADWED BR Fg/g GEL FIGURE 2 Apparent saturation of agarose-HSA. 1, 3, and 5 ml of plasma with 180 ,g BR/ml were passed over identical columns of 3 g of agarose-HSA.
In further experiments we have found that elution and storage in 70% (vol/vol) ethanol, chosen because of its potential bacteriostatic properties, was as effective as 50% ethanol and did not decrease the subsequent bilirubin-binding capacity of the beads.
Binding of other substances to agarose-HSA. The results of experiments on the binding and elution of other substances are summarized in Table III. Thyroxine was partially bound to agarose-HSA. The fraction of the material which bound could not be eluted with PBS but could be eluted with 50% ethanol.
Cortisol was slightly retarded by the beads as evidenced by the fact that a portion appeared in the prolonged PBS wash, but PBS did elute virtually all the material.
Three bile salts were tested. The unconjugated dihydroxy bile salt, chenodeoxycholate, bound strongly and could be eluted with 50% ethanol but not with 1 M sodium chloride-0.1 M sodium acetate, pH 5.0. The conjugated monohydroxy salt, taurolithocholate, was similarly bound and could be eluted with 50% ethanol. The conjugated trihydroxy salt, taurocholate, was definitely retarded by the beads but did elute with a prolonged PBS wash, presumably indicating a weak ionic or hydrogen bond linkage to the agarose-HSA. Sodium salicylate resembled taurocholate since it was retarded but eventually eluted completely with neutral buffer.
Digoxin, which does not bind significantly to albumin, and digitoxin, which does (19) , were studied at plasma levels in the ranges associated with clinical toxicity. As Table III shows, no digoxin was retained by the beads. By contrast, virtually all of the digitoxin was retained and was eluted by 50% ethanol but not by 1 M sodium chloride-0.1 M sodium acetate, pH 5.0.
Indocyanine green (not shown in Table III ) clearly bound to the beads. It could be eluted by 50% ethanol but not by 1 M sodium chloride-0.1 M sodium acetate, pH 5.0.
Studies with whole blood. The agarose-HSA beads were able to remove bilirubin from whole blood from a patient with the Crigler-Najjar syndrome (Table IV) .
We studied the effect on various hematologic and chemical parameters of the passage of fresh normal blood over agarose-HSA columns. When 10 ml of fresh blood anticoagulated with EDTA was passed over 5-g columns, the leukocyte count, differential, and platelet count were virtually unchanged (Table V) . The hemoglobin and red blood cell count were unchanged. A number of clotting factors of citrated whole fresh blood were likewise little affected by a single pass over agarose-HSA (Table VI). The erythrocyte osmotic fragility, tested both before and after incubation at 37°C, was unchanged by the passage of blood over agarose-HSA.
Among a large series of clinical chemistry studies, the following were not significantly changed by passage of whole blood over agarose-HSA: sodium, potassium, chloride, bicarbonate, phosphate, blood urea nitrogen, creatinine, uric acid, glucose, total protein, IgA, IgM, ceruloplasmin, serum glutamic oxaloacetic and pyruvic transaminase, alkaline phosphatase, fatty acids, triglycerides, cholesterol, protein-bound iodine, triiodothyronine, and thyroxine. The calcium fell from 6.6 to 4.7 and from 5.6 to 4.7 mg/100 ml in two experiments, and the magnesium from 1.2 to 0.9 mg/100 ml in one experiment (the column had been equilibrated with PBS containing no divalent cation). Minor reductions in IgG and increases in haptoglobin occurred in two experiments, and the iron and iron-binding capacity fell slightly in one experiment. There was no evident qualitative change in the immunoelectrophoresis of the serum from whole blood passed over an agarose-HSA gel column (Fig. 3) .
DISCUSSION
The experiments reported here arose from the need to deal with the declining clinical state of a young woman with congenital nonhemolytic jaundice (the CriglerNajjar syndrome) who had survived to age 18 before central nervous system signs developed which resembled kernicterus (20) . Removing unconjugated bilirubin from her circulation is the only function her otherwise normal liver fails to perform. We considerd, therefore, the problem of removing a substance so tightly bound to albumin that conventional methods of assisting removal are either ineffectual (dialysis) or impossibly cumbersome for chronic use (exchange transfusion and phototherapy). The reason that protein-bound substances cannot dialyze is not that there is no free compound. Rather, a high binding constant of the compound to the protein implies that a single molecule is statistically unlikely to have a long enough time for free diffusion after dissociating from the protein molecule to cross to and then through a dialysis membrane before meeting and binding to another protein molecule. If there were protein molecules within free diffusion distance of the plasma proteins but immobilized so that they would not move with the moving plasma stream, they ought to compete with the circulating protein molecules for the free compound and so remove the compound from the plasma stream. Eventually, a new steady state would be achieved with equilibrium of compound between free and immobilized protein. (23) . We have confirmed their observations on the binding of unconjugated bilirubin by these resins8 but have decided to develop a system employing specific proteins to bind particular substances because of the perhaps theoretical advantages for blood compatability and specificity.
In the experiments reported here, we found that it was possible to couple normal HSA, an abundantly available protein, to an insoluble matrix, agarose, in concentrations equal to those in serum; that the bound albumin retained a considerable ability to bind unconjugated bilirubin and other compounds normally bound to albumin; that the bound albumin competed efficiently with serum albumin passed over the gel adsorbent; that some of the substances retained on the gel adsorbent could be removed by elution with physiological salt solution, while others eluted with 50% ethanol in water; that such eluted gels retained their capacity to bind compounds with repeated reuse and storage at ice box temperatures; and that whole blood could be passed over such gels with only minor changes in white blood cells, platelets, clotting factors, and a variety of plasma proteins, electrolytes, and metabolites.
Although we did not measure the binding constant of the agarose-conjugated albumin, it appeared to compete efficiently for the bilirubin bound to circulating albumin and, in in vivo experiments, we have obtained some evidence of the achievement of equilibrium during prolonged in vivo perfusion (10) . The successful elution of the gel-bound bilirubin by plasma or solutions of HSA supports the concept that the binding of the BR to the conjugated HSA is not qualitatively different from the binding to circulating albumin.
Furthermore, the binding of other substances to the conjugated albumin resembles the binding to albumin in solution. Salicylate is relatively weakly bound to albumin (24) , and we have found that prolonged washing of the gel with physiological saline can remove the retarded 3 Unpublished observations. drug. Cortisol, which also binds weakly to albumin (25) , behaved similarly. Thyroxine, which in plasma linds largely to a group of specialized binding proteins of high affinity and, to a smiall extent, to albumin (26) , did bind partially to the gel. It would be interesting to know if only the albumin-bound material transferred to the gel.
The binding of bile salts to albumin has been studied in detail by Rudman and Kendall (27) The binding of digitoxin to the gels and the failure of digoxin to bind agree well with the studies on digitalis binding to albumin (19) by Smith. These experiments suggest that it may be possible to develop specific protein adsorbents other than albumin for the removal of particular metabolites or toxins from the circulation. Specific antibodies (28) (perhaps Fab fragments to avoid complement fixation), Clq (to remove circulating immune complexes), and other plasma transport proteins might be usefully attached to polymer beads. Despite our exploratory experiments with a variety of insoluble polymer beads, and despite the apparent biocompatability of agarose with whole human and rat blood, other insoluble matrices may eventually prove more suitable for human use. Derivatives of methacrylate or other plastics of known blood compatability may be useful (29) .
In the accompanying paper (10), our experience in using agarose-HSA gel adsorbents in vivo in rats to remove both conjugated and unconjugated bilirubin is presented and some other practical problems with these gels are discussed.
